These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 936286)

  • 1. Suppression of cell-mediated cytotoxicity by lymphocytes from tumor-bearing animals.
    Hellström I; Hellström KE; Kall MA; Nelson K; Pollack S
    Transplant Proc; 1976 Jun; 8(2):255-64. PubMed ID: 936286
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular and humoral immune interactions during neoplastic development.
    Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
    Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preferential efficicacy of immunocomplexes in the facilitation of tumor allografts].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1973 Nov; 124(4):567-72. PubMed ID: 4134880
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells.
    Meltzer MS; Bartlett GL
    J Natl Cancer Inst; 1972 Nov; 49(5):1439-43. PubMed ID: 4568090
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunostimulation of the growth of a syngeneic sarcoma primarily induced in mice by simian adenovirus SA7(C8)].
    Ageenko AI; Erkhov VS
    Vopr Onkol; 1977; 23(8):57-60. PubMed ID: 906408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic aspects of cancer.
    Sophocles AM; Nadler SH
    Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Disturbance of immune surveillance in tumor-bearing host (author's transl)].
    Haba S; Kitagawa M
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):930-8. PubMed ID: 4612620
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Proposed mechanisms by which autochthonous neoplasms escape immune rejection.
    Coggin JH; Ambrose KR; Dierlam PJ; Anderson NG
    Cancer Res; 1974 Aug; 34(8):2092-101. PubMed ID: 4366506
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antigenic reactivation in vitro of the cytotoxic activity of lymphoid cells from mice bearing syngeneic tumors].
    Schaaf-Lafontaine N
    C R Seances Soc Biol Fil; 1977; 171(3):663-6. PubMed ID: 144008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement phenomenon.
    Petrányi GG
    Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor antigens and tumor-host relationships.
    Baldwin RW; Price MR
    Annu Rev Med; 1976; 27():151-63. PubMed ID: 779594
    [No Abstract]   [Full Text] [Related]  

  • 18. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
    Barna B; Deodhar SD
    Cancer Res; 1975 Apr; 35(4):920-6. PubMed ID: 1116149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral factors influencing cell-mediated immune responses to tumour-associated antigens.
    Baldwin RW; Embleton MJ; Robins RA
    Proc R Soc Med; 1973 May; 66(5):466-8. PubMed ID: 4351926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.